Epoetin Alfa-epbx and Ranibizumab Intraocular
Determining the interaction of Epoetin Alfa-epbx and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: epoetin alfa
Brand name: Epogen, Procrit, Retacrit
Synonyms: Epoetin alfa, Epoetin Alfa
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epoetin Alfa-epbx-Ranibizumab ophthalmic
- Epoetin Alfa-epbx-Ranitidine
- Epoetin Alfa-epbx-Ranitidine Capsule
- Epoetin Alfa-epbx-Ranitidine Hydrochloride
- Epoetin Alfa-epbx-Ranitidine Injection
- Epoetin Alfa-epbx-Ranitidine Suspension
- Ranibizumab Intraocular-Epoetin alfa-epbx Injection
- Ranibizumab Intraocular-Epoetin beta and methoxy polyethylene glycol
- Ranibizumab Intraocular-Epogen
- Ranibizumab Intraocular-Epoprostenol
- Ranibizumab Intraocular-Epoprostenol Intravenous
- Ranibizumab Intraocular-Epoprostenol Sodium